From The Hindu BusinessLine
Center-Right Owned by The Hindu Group (Kasturi & Sons)HRV Pharma buys Germany-based clinical trial supplier Phatebo
What's behind this
HRV Pharma is acquiring Phatebo, a Germany‑based clinical trial supplier. The purchase will expand HRV Pharma’s operations beyond active pharmaceutical ingredients into finished formulations and provide the company with a licensed operating business in Germany.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
The acquisition will take it beyond active pharmaceutical ingredients into finished formulations and give it a licensed operating business in Germany.
-
right · 2 outlets
The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.
RSS excerpt
Deal expands company into finished formulations with a licensed operating business in Germany
